Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 54, Issue 77, 2007, Pages 1534-1538

  Kondo, Kazuhiro ^a   Chijiiwa, Kazuo ^a   Nagano, Motoaki ^a   Hiyoshi, Masahide ^a   Kai, Masahiro ^a   Maehara, Naoki ^a   Ohuchida, Jiro ^a   Nakao, Hiroyuki ^a   Ohkuwa, Yoshiaki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Hepatocellular carcinoma; Prognosis; Staging systems; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER LOBECTOMY; LIVER RESECTION; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT OUTCOME; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 34547634896     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Okuda K, Ohtsuki T, Obata H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985; 56:918-928.
2. The Cancer of the Liver Italian Program (CLIP) Investigators: A new prognostic system for hepatocellular carcinoma: a retrospective study of 453 patients. Hepatology 1998; 28:751-755.
3. Llovet JM, Brï C, Bruix J: Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19:329-338.
4. Chevret S, Trinchet J-C, Mathieu D, et al: A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol 1999; 31:133-141.
5. Leung TWT, Tang AMY, Zee B, et al: Construction of the Chinese university prognostic index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the liver Italian program staging system. A study based on 926 patients. Cancer 2002; 94:1760-1769.
6. Kudo M, Chung H, Osaki Y: Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new system, the Japan integrated staging score (JIS score). J Gastroenterol 2003; 38:207-215.
7. Nanashima A, Sumida Y, Morino S, et al: The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy. EJSO 2004; 30:765-770.
8. Tateishi R, Yoshida H, Shiina S, et al: Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut 2005; 54:419-425.
9. Wildi S, Pestalozzi BC, McCormack L, et al: Critical evaluation of the different staging systems for hepatocellular carcinoma. Br J Surg 2004; 91:400-408.
10. Pugh RN, Murray-Lyon IM, Dawson JL, et al: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
11. Liver cancer study group of Japan: General rules for the clinical and pathological study of primary liver cancer. 2nd English Edition. Tokyo: Kanehara Press, 2003.
12. Ueno S, Tanabe G, Sako K, et al: Discrimination value of the new western prognostic system (CILP score) for hepatocellular carcinoma in 662 Japanese patients. Hepatology 2001; 34:529-534.
13. Feinsten AR: Clinical biostatistics XVI. The process of prognostic stratification, Clin Pharmacol Ther 1972; 13:609-624.
14. Akaike H: A new look at statistical model identification. IEEE Transactions on Automatic Control 1974; AU-19:716-722.
15. Harrell Jr. FE, Lee KL, Califf RM, et al: Regression modeling strategies for improved prognostic prediction. Stat Med 1984; 3:143-152.
16. Carr BI: Hepatocellular carcinoma: current management and future trends. Gastroenterology 2004; 127(Suppl):s218-s224.
17. Sonoyama T, Ochiai T, Hironaka T, et al: Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma. Hepatogastroenterology 2003; 50:1078-1084.
18. Omata M, Tateishi R, Yoshida H, et al: Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004; 127(Suppl):s159-s166.